State adds new COVID-19 treatment for distribution across Illinois
— February 22, 2022On Feb. 11, the U.S. Food and Drug Administration (FDA) issued an emergency use authorization for a new monoclonal antibody, bebtelovimab, for the treatment of COVID-19. Bebtelovimab…